Skip to main content
. Author manuscript; available in PMC: 2008 Dec 12.
Published in final edited form as: J Mol Cell Cardiol. 2007 Dec 7;44(2):281–292. doi: 10.1016/j.yjmcc.2007.11.010

Fig. 6.

Fig. 6

Assessment of cardiac function. M-mode echocardiograms are shown at 4 weeks in group 1 (A), group 2 (B), group 3 (C) and group 4 (D). Left ventricular enddiastolic diameters (LVDD, E) and ejection fraction (EF) (F) in hearts treated with CXCR4 overexpressing MSCs (G2), or SDF-1α plus CXCR4 overexpression (G3) was significantly better (F) than in control group (G1), or miRNA-CXCR4 group (G4). All values were expressed as mean±S.E.M. *p<0.05 vs. control group (G1). n=6 for each group.